Incheon, South Korea

Ji Yoon Seok

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji Yoon Seok: Innovator in Cancer Treatment

Introduction

Ji Yoon Seok is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer. His innovative work has led to the creation of a unique compound that shows promise in combating various types of cancer.

Latest Patents

Ji Yoon Seok holds a patent for an N-containing heteroaryl derivative and a pharmaceutical composition comprising the same as an active ingredient for the prevention or treatment of cancer. This invention relates to a derivative that exhibits high inhibitory activity against various protein kinases, especially the ret proto-oncogene (RET) enzyme. The derivative has demonstrated an excellent effect in inhibiting the proliferation of medullary thyroid cancer cells and lung cancer cells that express RET fusion genes. This makes it a valuable candidate for treating cancers associated with RET fusion genes.

Career Highlights

Throughout his career, Ji Yoon Seok has worked with notable companies, including Voronoi Inc. and Voronoibio Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in cancer treatment.

Collaborations

Ji Yoon Seok has collaborated with talented individuals in his field, including Seo Hyun Jo and Hua Li. These partnerships have fostered an environment of innovation and have been instrumental in advancing his research.

Conclusion

Ji Yoon Seok is a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on the medical field. His innovative approaches and collaborations highlight his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…